Company
Gilead Sciences
Gilead Sciences is a biopharmaceutical company that researches, develops, and commercializes drugs for various diseases, including HIV/AIDS, cancer, and inflammatory conditions.
Why it’s in the news: It is in the news due to a major legal ruling on its innovation duties, its strategic ambitions in immunology, and controversy over its HIV drug patents.
Latest on Gilead Sciences
- STAT+: Why Gilead can’t stop talking about its ambitions in immunology
- STAT+: California Supreme Court sides with Gilead in ‘duty’ to innovate case
- STAT+: AIDS activists slam Biden R&D deal with Gilead over HIV prevention drug patents
- [via The Vanguard Group]
- Wikidata: The Vanguard Group — capital ownership — Gilead Sciences
- [via BlackRock]
- 13F: Journey Retirement Planning & Investment Management Llc holds Gilead Sciences ($1M)
- Wikidata: Gilead Sciences — located in — United States
- Wikidata: Gilead Sciences — operates in — pharmaceutical industry
- Wikidata: Gilead Sciences — capital ownership — Kite Pharma
- Wikidata: Gilead Sciences — capital ownership — Gilead Sciences Ltd
- Wikidata: Gilead Sciences — capital ownership — Gilead Sciences (Australia)
Connections
18 entities linked to Gilead Sciences across the news graph.
Also connected to (18)
United Statespharmaceutical industryKite PharmaGilead Sciences LtdGilead Sciences (Australia)Daniel O'DayBlackRockParrish Capital LlcFirst Financial Bank - Trust DivisionSTAT+: Why Gilead can’t stop talking about its ambitions in immunologySTAT+: California Supreme Court sides with Gilead in ‘duty’ to innovate caseSTAT+: AIDS activists slam Biden R&D deal with Gilead over HIV prevention drug patentsLarry FinkRob KapitoSusan WagnerJourney Retirement Planning & Investment Management LlcThe Vanguard GroupJohn C. Bogle